Document is current
Any future updates will be listed below
-
Authors
Recio-Rufián, Manuel https://orcid.org/0000-0001-8992-3677
López-Viñau, Teresa https://orcid.org/0000-0003-3493-6969
Gálvez-Soto, Víctor https://orcid.org/0000-0002-8312-5540
Cano, Ángela https://orcid.org/0000-0002-7801-9778
Ruiz-Montero, Rafael https://orcid.org/0000-0002-9113-6493
Gutiérrez-Gutiérrez, Belén https://orcid.org/0000-0002-9668-0770
Gracia-Ahufinger, Irene https://orcid.org/0000-0001-7714-6620
Peñalva, Germán https://orcid.org/0000-0001-6986-6230
Marín-Sanz, Juan Antonio
Marín-Sanz, Miriam https://orcid.org/0000-0002-0040-1053
Segorbe, David https://orcid.org/0000-0003-3086-0047
Pineda-Capitán, Juan Jesús
Muñoz-Rosa, Montserrat
Riazzo, Cristina
Giovagnorio, Federico
Ruiz-Arabi, Elisa https://orcid.org/0000-0002-5833-4834
Torres-Peña, José David
Castón, Juan José https://orcid.org/0000-0002-7477-2033
Machuca, Isabel https://orcid.org/0000-0003-3343-0085
Salcedo-Leal, Inmaculada
Martínez-Martínez, Luis https://orcid.org/0000-0002-6091-4045
Pérez-Nadales, Elena https://orcid.org/0000-0002-6796-1813
Torre-Cisneros, Julián https://orcid.org/0000-0003-1529-6302
,
Molina, Cristina
Natera, Clara
Torre-Giménez, Álvaro
Torre-Giménez, Julián
Vidal, Elisa
Causse, Manuel
Marfil, Eduardo
Guzmán-Puche, Julia
Blanco, Tania
Elías, Cristina
Córdoba, María
de la Fuente, Carmen
Rodriguez, Jorge
López-Miranda, José
Lorusso, Nicola
Pérez-Velasco, Laura
Arévalo-Álvarez, Rafael
Camacho-Ruano, María
Gómez-Sevilla, Fabiola
-
Funding
Funding for this research was provided by:
Universidad de Córdoba (1381158-R, 1381158-R)
Instituto de Salud Carlos III (PI23/00546 (KLEBGEN), PI21/01199 (KLEBMAN))
Center of Biomedical Investigation Network for Infectious Diseases (CB21/13/00049)
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 19 July 2025
First Online: 7 August 2025
Declarations
:
: This study was approved by Reina Sofía University Hospital Institutional Review Board (code HURS-4785), which waived the requirement for written informed consent.
: Not applicable.
: J.T.C. received honoraria for participating in an advisory board and educational activities for Pfizer, MSD and Shionogy, and research grants from Pfizer and MSD. AC received honoraria for participating in educational activities for Pfizer and Angelini. L.M.M. has been a consultant for MSD and Shionogi, has served as speaker for Merck, Astra-Zeneca, Astellas, Fastinov, Menarini and Shionogi and has received research support from Shionogi, Pfizer and MSD. All other authors declare no competing interest.
